发明名称 |
Pre-or post-exposure treatment for filovirus or arenavirus infection |
摘要 |
The compositions and methods of the invention described herein provide pre- or post-exposure treatments against filovirus or arenavirus infection by expressing one or more genes (e.g., two ore more genes) from filoviruses or arenaviruses in a delivery vehicle (e.g., a recombinant viral vector or a liposome). |
申请公布号 |
US8796013(B2) |
申请公布日期 |
2014.08.05 |
申请号 |
US200812809348 |
申请日期 |
2008.12.17 |
申请人 |
Trustees of Boston University;Boston Medical Center Corporation |
发明人 |
Geisbert Thomas W. |
分类号 |
C12N15/00;A61K39/12 |
主分类号 |
C12N15/00 |
代理机构 |
Clark & Elbing LLP |
代理人 |
Clark & Elbing LLP ;Clark Paul T.;Armstrong Todd |
主权项 |
1. A method of inhibiting or treating infection by Sudan species of Ebola virus (SEBOV) in a subject exposed to said SEBOV, said method comprising administering to said subject no later than 30 minutes after infection by said SEBOV a pharmaceutical composition comprising a recombinant viral vector that encodes at least a glycoprotein from said SEBOV, wherein the glycoprotein is heterologous to the viral vector. |
地址 |
Boston MA US |